Concepedia

Serum high-density lipoprotein cholesterol serves as a prognostic marker for light-chain cardiac amyloidosis

Tingjie Yang, Ke Wan, Rizhen Song, Xinli Guo, Yuanwei Xu, Jie Wang, Qing Zhang, Kevin Alexander, Ronglih Liao, Yucheng Chen

International Journal of Cardiology · 2020 · 14 citations · 18 references

DOI

Concepts

References

18

Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy et al. · Journal of Clinical Oncology · 2012 · 1.1K citations · Full text

, , +15

Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle et al. · Journal of Clinical Oncology · 2004 · 973 citations · Full text

, , +15

High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

Gillian Cockerill, Kerry‐Anne Rye, Jennifer R. Gamble et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1995 · 777 citations · Full text

, , +17

A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis

Ashutosh Wechalekar, Stefan Schönland, Efstathios Kastritis et al. · Blood · 2013 · 516 citations

, , +6

High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3

Dominic De Nardo, Hajime Kono, Reiko Seki et al. · Nature Immunology · 2013 · 461 citations · Full text

, , +16